PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 48 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,810 | -68.3% | 687,068 | +7.6% | 0.00% | -100.0% |
| Q1 2024 | $43,552 | +826.2% | 638,601 | +219.2% | 0.00% | – |
| Q4 2023 | $4,702 | +13.2% | 200,090 | +245.0% | 0.00% | – |
| Q3 2023 | $4,152 | +17.2% | 58,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,543 | +52.6% | 58,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,322 | -8.5% | 58,000 | -1.5% | 0.00% | – |
| Q4 2022 | $2,538 | – | 58,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,679,584 | 0.10% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,540,545 | 0.05% |
| Telemetry Investments, L.L.C. | 125,114 | $5 | 0.01% |
| Q Global Advisors, LLC | 170,785 | $7 | 0.00% |
| Atalaya Capital Management LP | 225,000 | $9,000 | 0.00% |
| DIFESA CAPITAL MANAGEMENT, LP | 62,500 | $2,456 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $51,000 | 0.00% |
| PERISCOPE CAPITAL INC. | 957,098 | $40,600 | 0.00% |
| MMCAP International Inc. SPC | 375,000 | $16,162 | 0.00% |
| Sage Rock Capital Management LP | 91,999 | $3,965 | 0.00% |